| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970327 | The Journal of Heart and Lung Transplantation | 2014 | 8 Pages |
Abstract
Our results suggest that an elevation of PS+ microparticle levels may be associated with adverse clinical events. Thus, measuring PS+ microparticle levels in LVAD-supported patients may help identify patients at increased risk for adverse events.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Angelo MD, Ruben MD, Joggy K. MD, Anita RN, Angela L. BS, Subhashree PhD, K. Vinod PhD, Andrew MD, Leo MD, Maria PhD, Vei-Vei MS, Hari R. MD, Reynolds M. MD, Jing Fei MD, O.H. MD,